- All
- Company news
- CPHI 2025
- New medicines
- Past Events
- WHX 2026
FDA Approves Accrufer (Ferric Maltol): First Prescription Oral Treatment for Iron Deficiency in Pediatric Patients
Oral Treatment
Orforglipron: A New Breakthrough in Obesity Treatment with Rapid FDA Approval
New Oral Weight Loss Drug
FDA Approves Aqvesme (Mitapivat): First Oral Treatment for Anemia in Thalassemia
First Oral Thalassemia Treatment
Comprehensive Guide to Choosing a Reliable and Vital Drug Supplier in Europe
Complete Guide to Choosing Vital Drug Suppliers in Europe
International medicine Logistics: Challenges and Practical Solutions from Lenus Health’s Perspective
Challenges and Practical Solutions
Lenus Health Exclusive Report from MEDICA 2025 Somewhere Between Innovation, Crowds, and Life-Saving Coffee
Exploring Opportunities and Market Trends
Our Experience at CPhI Frankfurt 2025: Exploring Opportunities and Market Trends
Exploring Opportunities and Market Trends